| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,854 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,079,680 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
787,387 |
|
|
| Total
Value |
$65,018,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -13.1%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-08-10 |
4 |
S |
$20.20 |
$724,917 |
D/D |
(35,886) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-08-17 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-02-29 |
4 |
S |
$37.91 |
$805,798 |
D/D |
(21,142) |
4,071 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-03-03 |
4 |
S |
$38.10 |
$76,239 |
D/D |
(2,000) |
11,213 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-03-04 |
4 |
S |
$38.00 |
$152,000 |
D/D |
(4,000) |
7,213 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-05-09 |
4 |
S |
$38.39 |
$310,031 |
D/D |
(8,000) |
8,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-05-12 |
4 |
S |
$39.15 |
$195,791 |
D/D |
(5,000) |
3,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-05-15 |
4 |
S |
$39.10 |
$195,546 |
D/D |
(5,000) |
3,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-12-08 |
4 |
S |
$17.00 |
$67,988 |
D/D |
(4,000) |
10,917 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2009-08-07 |
4 |
S |
$15.95 |
$31,902 |
D/D |
(2,000) |
57,440 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2009-08-10 |
4 |
S |
$15.69 |
$31,889 |
D/D |
(2,000) |
55,440 |
0 |
- |
|
| NGSX |
Neurogesx Inc |
Director |
– • – |
2009-08-14 |
4 |
S |
$7.18 |
$18,991 |
D/D |
(2,621) |
24,740 |
0 |
- |
|
| NGSX |
Neurogesx Inc |
Director |
– • – |
2009-08-17 |
4 |
S |
$7.21 |
$29,844 |
D/D |
(4,119) |
20,621 |
0 |
- |
|
| NGSX |
Neurogesx Inc |
Director |
– • – |
2009-11-19 |
4 |
S |
$8.15 |
$32,802 |
D/D |
(4,000) |
15,621 |
0 |
- |
|
| NGSX |
Neurogesx Inc |
Director |
– • – |
2009-11-20 |
4 |
S |
$8.40 |
$16,865 |
D/D |
(2,000) |
13,621 |
0 |
- |
|
| NGSX |
Neurogesx Inc |
Director |
– • – |
2010-05-19 |
4 |
S |
$8.71 |
$13,065 |
D/D |
(1,500) |
12,121 |
0 |
- |
|
| NGSX |
Neurogesx Inc |
Director |
– • – |
2010-05-24 |
4 |
S |
$8.06 |
$16,131 |
D/D |
(2,000) |
10,121 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-08-30 |
4 |
S |
$20.71 |
$62,126 |
D/D |
(3,000) |
99,067 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-09-08 |
4 |
S |
$22.22 |
$22,220 |
D/D |
(1,000) |
95,067 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-11-02 |
4 |
S |
$25.64 |
$89,750 |
D/D |
(3,500) |
93,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-11-03 |
4 |
S |
$25.46 |
$101,824 |
D/D |
(4,000) |
93,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-11-08 |
4 |
S |
$25.78 |
$51,569 |
D/D |
(2,000) |
93,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-11-18 |
4 |
S |
$25.99 |
$25,988 |
D/D |
(1,000) |
93,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-11-23 |
4 |
S |
$27.02 |
$27,021 |
D/D |
(1,000) |
93,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-12-06 |
4 |
S |
$27.17 |
$27,174 |
D/D |
(1,000) |
93,567 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
